PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has ...
BASEL, Switzerland--(BUSINESS WIRE)--Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete Genomics, USA, ...
Aberdeen Proving Ground, MD – Future battlefields require an on-the-go approach to the identification of whatever biological threat our warfighters may come across. One such approach – Far-Forward ...
Her computations allow physicians to more quickly diagnose and treat life-threatening genetic diseases. Sneha Goenka is one of MIT Technology Review’s 2025 Innovators Under 35. Meet the rest of this ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
Zacks Investment Research on MSN
PacBio stock up on HiFi sequencing adoption for major SUDC research
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina's next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 ...
Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results